Non-Communicable Diseases: NPCDCS ... - SIHFW Rajasthan

More documents

Recommendations

Info

Visual Inspection using 4% Acetic acid (VIA): Acetic acid causes dehydration of the cells Surface coagulation of proteins reducing the transparency of the epithelium. <strong>SIHFW</strong>: An ISO:9001:2008 certified Institution 232
VIA Category Negative Positive Criteria for Categorizing VIA Test Results Description •Noaceto-white lesions • Transparent lesions or faint patchy lesions without definite margins • Nabothian cysts becoming aceto-white • Faint line like aceto-whitening at the junction of columnar and squamous epithelium • Aceto-white lesions far away from the transformation zone. • Distinct, opaque aceto-white area • Margin should be well defined, may or may not be raised • Abnormality close to the squamocolumnar junction in the transformation zone and not far away from the os. INvasive Obvious growth or ulcer in the cervix. Acetowhite area may not be visible because of bledding. <strong>SIHFW</strong>: An ISO:9001:2008 certified Institution 233
Page 1 and 2:
Non-Communicable Diseases: NPCDCS &
Page 3 and 4:
Risk factors and NCDs largely preve
Page 5 and 6:
Drivers of NCDs SIHFW: an ISO 9001:
Page 7 and 8:
SIHFW: an ISO 9001:2008 certified I
Page 9 and 10:
Epidemiological Transition Communi
Page 11 and 12:
Challenges Many communicable disea
Page 13 and 14:
SIHFW: an ISO 9001:2008 certified I
Page 15 and 16:
Magnitude SEAR-2008: 14.5million t
Page 17 and 18:
50 45 40 35 30 25 Estimated %of pre
Page 19 and 20:
Trends in estimated %of deaths 80%
Page 21 and 22:
Estimated and Projected Deaths due
Page 23 and 24:
Pop.(2010): 1 224 614 327 Age stand
Page 25 and 26:
Metabolic Risk factor Trends 126 Me
Page 27 and 28:
26 Mean BMI 24 22 Male 20 Female 18
Page 29 and 30:
Reported Cases & Deaths due to NCD-
Page 31 and 32:
Total Number of Diabetic Cases - Ra
Page 33 and 34:
Reported Deaths :Type 1 DM- Distric
Page 35 and 36:
District Reported Deaths of Type 2
Page 37 and 38:
Reported Cases of Deaths Due to Can
Page 39 and 40:
District -wise reported Cancer Deat
Page 41 and 42:
SIHFW: An ISO:9001:2008 certified I
Page 43 and 44:
Implications of ↑ burden of NCDs
Page 45 and 46:
MDG-6 NCD burden threatenst the (Co
Page 47 and 48:
2% annual reduction in Chronic Dise
Page 49 and 50:
Answer to the problem: ACT NOW Prev
Page 51 and 52:
Risk factor/disease Tobacco use: Us
Page 53 and 54:
Action at National Level: Two comp
Page 55 and 56:
Strategies Prevention through beha
Page 57 and 58:
Services Preventive, promotive , c
Page 59 and 60:
Facility DH Services Early diagnosi
Page 61 and 62:
Institutional Framework Integratio
Page 63 and 64:
Page 65 and 66:
Screening MO to do: To conduct com
Page 67 and 68:
Work closely with other sectors/ de
Page 69 and 70:
Surveillance Surveillance is the on
Page 71 and 72:
Risk Factor Surveillance: Focus …
Page 73 and 74:
Risk factors common to major non-co
Page 75 and 76:
Levels of Risk Factor Surveillance
Page 77 and 78:
Actions at Hospitals Proper depict
Page 79 and 80:
Page 81 and 82:
Structure re of presentation Risk
Page 83 and 84:
Risk factor in NCD Any attribute,
Page 85 and 86:
Risk factors May be truly causativ
Page 87 and 88:
NHD of NCD Changes in life style st
Page 89 and 90:
The WHO STEP approach to Surveillan
Page 91 and 92:
STEPS emphasizes that small amounts
Page 93 and 94:
SIHFW: an ISO 9001: 2008 certified
Page 95 and 96:
Step1:Questionnaire Based Assessmen
Page 97 and 98:
Step 3: Biochemical Measurements D
Page 99 and 100:
Core Items Expanded Items Optional
Page 101 and 102:
Behavioral Risk Factors “Actions/
Page 103 and 104:
Modifiable Risk Factor: 2008 estima
Page 105 and 106:
B. Diabetes ‣ Obesity ‣ Sedenta
Page 107 and 108:
D. Cancer ‣ Environment ‣ Life
Page 109 and 110:
Risk factors and level of NCD preve
Page 111 and 112:
Goals of implementing these guideli
Page 113 and 114:
Follow up Once the condition of th
Page 115 and 116:
High risk With established cardiov
Page 117 and 118:
If cholestrol can not be measured S
Page 119 and 120:
Prevention of CVD (according to ind
Page 121 and 122:
NPCDCS Components Prevention throu
Page 123 and 124:
Thank you SIHFW: An ISO:9001:2008 c
Page 125 and 126:
Problem on the rise : NCDs MI HT CO
Page 127 and 128:
Major diet related NCDs Diabetes Ca
Page 129 and 130:
Type of cancers Risk factors Diet R
Page 131 and 132:
Prominent risk factor Disease Heart
Page 133 and 134:
Life Style Modification Primary Pr
Page 135 and 136:
Burden of the Bulge In India 1 in
Page 137 and 138:
Android : Upper-body obesity--apple
Page 139 and 140:
Assessment of central obesity Wais
Page 141 and 142:
Why is this happening Drivers of th
Page 143 and 144:
Nutrition transitions: Absolute cau
Page 145 and 146:
Body Mass Index (BMI ) Quetlet’s
Page 147 and 148:
Classification BMI Classification W
Page 149 and 150:
Sleep apnea and respiratory problem
Page 151 and 152:
Weight management Weight gain Calor
Page 153 and 154:
Weight loss goals Realistic Achie
Page 155 and 156:
Lifestyle medicine: Need for change
Page 157 and 158:
Dietary interventions Managing g /
Page 159 and 160:
Life style modification & Diet Bala
Page 161 and 162:
SIHFW: an ISO 9001: 2008 certified
Page 163 and 164:
Total energy requirement Total ener
Page 165 and 166:
Diet for NCD: Main focus ‣ Gradua
Page 167 and 168:
Promoting Healthy lifestyle le Tra
Page 169 and 170:
Strategies for Obesity Prevention e
Page 171 and 172:
Tips for weight reduction Slow and
Page 173 and 174:
‣ Avoid fried foods and bakery pr
Page 175 and 176:
When to eat Set aside a time for
Page 177 and 178:
Way to eat Eat slowly. Chew prop
Page 179 and 180:
Recommendations in preventing diabe
Page 181 and 182: Calculating balanced diet Know Rec
Page 183 and 184: How to calculate balance diet Step
Page 185 and 186: Key recommendations -Diet • Frui
Page 187 and 188: Thank you SIHFW: an ISO 9001: 2008
Page 189 and 190: Structure re of presentation Basic
Page 191 and 192: What is Cancer SIHFW: an ISO 9001:
Page 193 and 194: Growth of Cells • Undesirable •
Page 195 and 196: Common Cancer sites Male- • Mout
Page 197 and 198: Prefix adeno- chondro- Meaning Nami
Page 199 and 200: India 0.8 million new cases/year
Page 201 and 202: Five Common Cancers Rank World Indi
Page 203 and 204: Issues in Cancer control Burden of
Page 205 and 206: Cancer patterns Predominance of To
Page 207 and 208: Prevention ention and screening Se
Page 209 and 210: Early diagnosis ‣ Individual’s
Page 211 and 212: Diagnosis Radiological Biochemica
Page 213 and 214: Cancer Interventions in different E
Page 215 and 216: 350 Age wise distribution of deaths
Page 217 and 218: Common Cancer in Male 50000 45000 4
Page 219 and 220: No of Cancer Deaths -India 350 300
Page 221 and 222: Cancer Deaths -Rajasthan 60 50 40 5
Page 223 and 224: District wise Reported Cancer Death
Page 225 and 226: Projected Cases of Oral Cancer in I
Page 227 and 228: Age - wise distribution of Deaths d
Page 229 and 230: Symptoms of Cervical Cancer Post-m
Page 231: Evaluation and Management after Pap
Page 235 and 236: Cryotherapy (ablation) Management
Page 237 and 238: Age - wise distribution of Deaths d
Page 239 and 240: Sign and Symptoms A lump or thicke
Page 241 and 242: SIHFW: An ISO:9001:2008 certified I
Page 243 and 244: Diagnosis Breast awareness & breas
Page 245 and 246: Health professionals can - Key Mess
Page 247 and 248: Projected Cases of Lung Cancer in I
Page 249 and 250: Symptoms Persistent cough or worse
Page 251 and 252: National Programme SIHFW: An ISO:90
Page 253 and 254: National Cancer Registry Programme
Page 255 and 256: Schemes under NCCP Recognition of
Page 257 and 258: SIHFW: An ISO:9001:2008 certified I
Page 259 and 260: District Services under NCCP Healt
Page 261 and 262: Medical college Health Promotion &
Page 263 and 264: Why include Cancer In NPCDCS No u
Page 265 and 266: Objective e of TCC Scheme Develop
Page 267 and 268: Thank You For more details log on t
Page 269 and 270: Definition ‣ Group of brain dysfu
Page 271 and 272: Burden of Disease 7000000 6000000 5
Page 273 and 274: Risk Factors ‣ Age and Sex ‣ Hy
Page 275 and 276: Cerebrovascular Accident Risk Facto
Page 277 and 278: Cerebrovascular Accident Anatomy of
Page 279 and 280: Ischemic Cascade Cerebrovascular Ac
Page 281 and 282: ‣ Trouble in walking Symptoms ‣
Page 283 and 284:
Identification of an acute event S
Page 285 and 286:
Diagnosis: CT without contrast Cer
Page 287 and 288:
Cerebrovascular Accident Classifica
Page 289 and 290:
CVA Recognition SIHFW: An ISO:9001:
Page 291 and 292:
Cerebrovascular Accident Thrombotic
Page 293 and 294:
Cerebrovascular Accident Common Sit
Page 295 and 296:
Page 297 and 298:
Cerebrovascular Accident Embolic St
Page 299 and 300:
Cerebrovascular Accident Goals for
Page 301 and 302:
Cerebrovascular Accident Hemorrhage
Page 303 and 304:
Page 305 and 306:
Cerebrovascular Accident Hemorrhagi
Page 307 and 308:
Delayed Neurological deficit in Re
Page 309 and 310:
Page 311 and 312:
Hemorrhagic-Subarachnoid Cerebral A
Page 313 and 314:
Cerebrovascular Accident Clinical i
Page 315 and 316:
Cerebrovascular Accident Clinical M
Page 317 and 318:
Page 319 and 320:
Cerebrovascular Accident Treatment
Page 321 and 322:
Cerebrovascular Accident Diagnostic
Page 323 and 324:
CVA - Treatment Goals Surgical Tre
Page 325 and 326:
Drug Therapy Cerebrovascular Accide
Page 327 and 328:
Cerebrovascular Accident Rehabilita
Page 329 and 330:
Cardio-Vascular Diseases SIHFW: An
Page 331 and 332:
Source: WHO Burden of Disease Numb
Page 333 and 334:
Cardiovascular Diseases group of di
Page 335 and 336:
Newly emerging CVD risk factors ‣
Page 337 and 338:
Resource Scenario-1 Scenario-2 Scen
Page 339 and 340:
Prevention of CVD Heart disease and
Page 341 and 342:
Hypertension “ high blood pressur
Page 343 and 344:
Classification Primary / Essential
Page 345 and 346:
Epidemiological Determinants Risk/
Page 347 and 348:
Symptoms ‣ Headache ‣ Drowsines
Page 349 and 350:
Criteria for diagnosing high blood
Page 351 and 352:
Headache (severe hypertension) < mo
Page 353 and 354:
Physical examination should include
Page 355 and 356:
Desirable: (at CHC/sub-district/dis
Page 357 and 358:
Life style advice is advocated for
Page 359 and 360:
Treatment Goals The aim should be
Page 361 and 362:
Diuretics Thiazide Inhibit Na + /C
Page 363 and 364:
Beta blockers Act by decreasing ca
Page 365 and 366:
α adrenergic blockers Lower BP by
Page 367 and 368:
Medicines are tailored depending on
Page 369 and 370:
‣ Start with calcium channel bloc
Page 371 and 372:
Compelling Indications for Compelli
Page 373 and 374:
Management of Hypertension at diffe
Page 375 and 376:
Follow-up and Monitoring Patients
Page 377 and 378:
Ischemic Heart Disease Myocardial i
Page 379 and 380:
Burden of IH Disease 10000000 22367
Page 381 and 382:
Symptoms ‣ Abrupt, unexpected car
Page 383 and 384:
Treatment of IHD ‣ Medical treatm
Page 385 and 386:
Management & Prevention: Modifying
Page 387 and 388:
‣ Weakness in sternocleidomastoid
Page 389 and 390:
Prevention ention ‣ Strokes are p
Page 391 and 392:
‣ Physical therapy to improve str
Page 393 and 394:
Rheumatic heart diseases ‣ Compli
Page 395 and 396:
‣ Breathlessness ‣ Fatigue ‣
Page 397 and 398:
Prevention ‣ Seek immediate medic
Page 399 and 400:
Page 401 and 402:
Conceptualization ation of NPHCE U
Page 403 and 404:
Objectives es Provide Preventive,
Page 405 and 406:
Ageing Ageing is a progressive biol
Page 407 and 408:
Ageing means….. Demographers: A
Page 409 and 410:
Ageing Progressive and generalized
Page 411 and 412:
Some Facts! World population of 6.
Page 413 and 414:
Projections 60+ 24 million in 1961
Page 415 and 416:
India: Some Facts! Life expectancy
Page 417 and 418:
Household population p + 60 Age By
Page 419 and 420:
Ageing: Common Myths Most elderly
Page 421 and 422:
Integumentary System Production of
Page 423 and 424:
Circulatory System Heart muscle be
Page 425 and 426:
Nervous System Progressive loss of
Page 427 and 428:
Urinary System Decreased circulati
Page 429 and 430:
Reproductive e System Female: vagi
Page 431 and 432:
Psychosocial Changes of Aging Lone
Page 433 and 434:
Psychosocial changes can be a major
Page 435 and 436:
Dementia Term used to describe a l
Page 437 and 438:
Alzheimer’s Disease (continued)
Page 439 and 440:
Meeting the Needs of the Elderly G
Page 441 and 442:
Page 443 and 444:
Gender and Ageing g in India Discr
Page 445 and 446:
Care - Services for Elderly l in In
Page 447 and 448:
Primary Health Center Training of
Page 449 and 450:
How to achieve it Ati Active advoc
Page 451 and 452:
Mental Health : Problem, Strategies
Page 453 and 454:
Health "Health is a state of compl
Page 455 and 456:
Mental Health Problems in India 1%
Page 457 and 458:
Extent of the problem… Mental He
Page 459 and 460:
Mental Health Resources In India Ma
Page 461 and 462:
Mental Health Resources In India…
Page 463 and 464:
Mental Health Resources in India 2
Page 465 and 466:
Objectives National Mental Health P
Page 467 and 468:
Essentials of DMHP 1. A decentraliz
Page 469 and 470:
Restrategised NMHP 2003 Components
Page 471 and 472:
Integration of NMHP in NRHM Nation
Page 473 and 474:
DMHP Evaluation Independent evalua
Page 475 and 476:
NMHP Achievement Scheme Financial S
Page 477 and 478:
Failures It is top down approach
Page 479 and 480:
Urban Mental Health Meta analysis b
Page 481 and 482:
NGO Work In INDIA SCARF (Schizophr
Page 483 and 484:
Mental Health NGO Activities Treat
Page 485 and 486:
Community Awareness Role of media
Page 487 and 488:
Tobacco As per Global Adult tobacc
Page 489 and 490:
Stepped Care Approach in Substance
Page 491 and 492:
Future Direction Vision i 2020: Roa
Page 493:
For more details log on to www. sih
show all

Non-Communicable Diseases: NPCDCS ... - SIHFW Rajasthan

Create successful ePaper yourself

Delete template?

Save as template?